Researchers have developed a way to grow and genetically engineer progenitor cells that produce macrophages, first responder immune cells with potential for new immunotherapies against cancer and other diseases. Macrophages look almost built for the hardest parts of cancer therapy.…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.